Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06840210 · ClinicalTrials.gov registry record
Effectiveness-Implementation Evaluation of Acute Kidney Injury Decision Support
A clinical trial, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 200,000
- Enrollment target
NCT06840210: Recruiting study, sponsored by Johns Hopkins University.
NCT06840210 is a clinical trial that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 200,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06840210 is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 200,000 participants
- Enrollment target
Study Summary
Study Purpose: This study is testing an artificial intelligence (AI)-powered clinical decision support (CDS) system designed to help emergency department (ED) doctors detect and manage acute kidney injury (AKI) earlier. The goal is to see whether the tool improves patient care, clinician decision-making, and hospital outcomes when used in real-world ED settings. Study Design: The AI tool will be gradually introduced at three hospital EDs: Johns Hopkins Hospital (JHH) Bayview Medical Center (BMC) Howard County General Hospital (HCGH) Before the tool is activated, it will run in the background to collect baseline data without influencing care. Once implemented, doctors will receive training, and researchers will track how often the tool is used and whether it improves AKI care. What the Study Measures: Process Outcomes: Does the tool help doctors identify AKI sooner, avoid harmful medications, and improve decision-making about hospitalization? Clinical Outcomes: Does the tool reduce the number and severity of AKI cases and improve kidney-related health outcomes? Implementation Outcomes: Do ED doctors find the tool useful? Does it fit into the ED doctor's workflow without slowing the ED doctor's down? Expected Impact: If successful, the AI tool could be expanded to other hospitals and used to improve early detection and treatment of AKI, reducing kidney complications and improving patient care nationwide.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200,000 participants |
| Start Date | 2026-03-10 |
| Est. Completion | 2030-12-01 |
What NCT06840210 shows while recruiting
NCT06840210 is an observational study that tracks outcomes without assigning an intervention. Its 200,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT06840210 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06840210 about?
NCT06840210 is a clinical study titled "Effectiveness-Implementation Evaluation of Acute Kidney Injury Decision Support". Study Purpose: This study is testing an artificial intelligence (AI)-powered clinical decision support (CDS) system designed to help emergency department (ED) doctors detect and manage acute kidney injury (AKI) earlier. The goal is to see whether the tool improves patient care, clinician decision-ma...
What is the current status of trial NCT06840210?
This trial is currently recruiting. The enrollment target is 200,000 participants. The study started on 2026-03-10. Estimated completion is 2030-12-01.
Who is sponsoring clinical trial NCT06840210?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06090578 · 180,000 participants · NA
TabCAT Brain Health Assessment in Primary Care
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT04735835 · 250,000 participants · NA
Personalized Responses to Dietary Composition Trial 3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI